Article | 2025 Clinical Trials at the Summit
Trial Data Indicates Cell Therapy May Reverse GA Damage
Surgical delivery of OpRegen RPE cell therapy produced sustained anatomical and functional improvements in geographic atrophy, according to 36-month data.







